[Peculiarities of infusion-transfusion therapy for purulent-septic diseases of respiratory organs].
The oxygen-transporting blood surrogate perftoran was included in the infusion-transfusion therapy programme on various stages in the treatment of purulent-septic diseases of respiratory organs. Application of this method of intensive therapy had promoted the blood oxygentransporting function improvement in patients, as well as the respiratory-hemic hypoxia severity lowering and their treatment efficacy raising.
Gerasimenko
P V
PV
D001785:Blood Gas Monitoring, Transcutaneous; D001802:Blood Substitutes / Q000008:administration & dosage*; D017707:Erythrocyte Transfusion; D005466:Fluorocarbons / Q000008:administration & dosage*; D006801:Humans; D000860:Hypoxia / Q000097:blood / Q000209:etiology / Q000628:therapy*; D012141:Respiratory Tract Infections / Q000097:blood / Q000150:complications / Q000628:therapy*; D016896:Treatment Outcome
D001802:Blood Substitutes; D005466:Fluorocarbons; C063334:perftoran